Antibody Therapeutics Patients First!

투자공지사항

기업설명회(IR)_19.11.29
  • 글쓴이 PharmAbcine
  • 작성일 2019-12-02 11:47:09
  • 조회수 8026
첨부파일 PharmAbcine at KOSDAQ IR 20191129.pdf
※ The KRX neither affirms nor certifies the accuracy or the correctness of posted on the KRX English KIND and assumes no responsibility for the use of information expressed or implied therein. Because IR Informations in English are made voluntarily by listed company.
목록





이전글 파멥신, 개인정보관리규정
다음글 파멥신, 애널리스트 리포트 (한양증권)